UP STRATEGIC WEALTH INVESTMENT ADVISORS LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2011649 PITTSBURGH, PA

Back to GILD Full portfolio

Position in GILD

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$593,798

-$61,241 QoQ

Shares Held

4,700

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.59%

of 13F equity value

Holder Rank

#1,301

of 2,266 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

UP STRATEGIC WEALTH INVESTMENT ADVISORS LLC holds $4,383,847 across 6 Drug Manufacturers - General names. GILD ranks #4 (13.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,328	$1,592,843
2	ABBV	AbbVie Inc.	3,294	$828,902
3	JNJ	Johnson & Johnson	2,822	$716,703
4	GILD	Gilead Sciences, Inc. This page	4,700	$593,798
5	MRK	Merck & Co., Inc.	3,256	$418,396
6	AMGN	Amgen Inc	644	$233,205

All Filings in GILD

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$593,798	4,700	0.0%	Shares	Sole	2026-08-07
2026-03-31	$655,039	4,700	+5.5%	Shares	Sole	2026-05-12
2025-12-31	$547,052	4,457	0.0%	Shares	Sole	2026-02-10
2025-09-30	$494,727	4,457	-0.2%	Shares	Sole	2025-11-19
2025-06-30	$495,034	4,465	-11.1%	Shares	Sole	2025-08-12
2025-03-31	$562,939	5,024	+3.7%	Shares	Sole	2025-05-15
2024-12-31	$447,440	4,844	+5.2%	Shares	Sole	2025-02-14
2024-09-30	$385,915	4,603	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.